CRTH2 antagonism blocks skin inflammation
=========================================

Here, **Boehme *et al.* (p. 1)** examine ovalbumin-induced murine atopic dermatitis treated with an antagonist of CRTH2 (chemoattractant receptor homologous molecule expressed on T~h~2 cells) --- one of the PGD~2~ receptors ---and show decreased cutaneous inflammation and antigen-specific antibody production, suggesting a pivotal role for this receptor. The authors then describe specific effects on dendritic cell functions.

*F. novicida* disrupts STAT1 signalling
=======================================

*Francisella novicida* models tularaemia, but the role of signal transducer and activator of transcription 1 (STAT1) in this disease is unknown. **Satoskar and colleagues (p. 19)** show that STAT1 --/-- mice have more-severe pathology than wild-type mice after infection. *F. novicida* also suppresses a range of functions in macrophages, in particular, IFN production and activation of CD4^+^ T cells.

γc cytokines and survival of CD127^+^ T cells
=============================================

CD127 (IL-7Rα) is a marker of CD8^+^ memory cells. **Angel and colleagues (p. 29)** examine responses to other cytokines that signal via γc, and show different responses to cell division and anti-apoptotic signals between CD8**^+^**CD127**^+^** and CD8**^+^**CD127**^--^** cells. The authors discuss implications for diseases in which CD127 expression varies, for example cancer and progressive viral infections such as HIV.

The B-1 cell repertoire is determined by the pre-BCR
====================================================

The skewed repertoire of the enigmatic, phosphatidylcholine-reactive B-1 B cell subset was thought to be due to antigen-driven clonal selection and expansion; however, **Karasuyama and colleagues (p. 43)** show that the characteristic B-1 cell J-chain usage is established in the foetal liver early in B cell ontogeny and is antigen-independent. The authors also describe possible molecular mechanisms and consequences.

Two phenotypes of melanoma-specific T cells expand *in vitro*
=============================================================

**Tarazona and colleagues (p. 53)** examine *in vitro* expansion of naïve human melanoma-specific CD8**^+^** cells. Some donors' cultures have low levels of expansion, but show high cytotoxicity and a CD45RA**^+^**CCR7**^--^** phenotype; other donors' cultures have higher expansion but are noncytotoxic, with a CD45RA**^--^**CCR7**^--^** phenotype. These results have clear importance for generating cells in adoptive immunotherapy.

Immunodominant epitopes of SARS
===============================

Severe acute respiratory syndrome (SARS) is potentially a major public-health problem; it is caused by a coronavirus (CoV). Using tetramer-guided epitope mapping, **Kwok and colleagues (p. 63)** identified four immunodominant HLA-DR0401-restricted epitopes of SARS-CoV in healthy, naïve subjects. These findings are important for future vaccination strategies and the technique can be applied to other emerging pathogens.

IFN-γ and IL-6 control superantigen-mediated T cell death
=========================================================

Some pathogens contain superantigens, which cause excessive activation and death of CD4**^+^** T cells in many diseases. **Murakami and colleagues (p. 73)** reveal an important role for CD8**^+^** T cell derived IFN-γ in this cell death. The authors also show that IL-6 in the CD8**^+^** cells can suppress this process. This novel axis may represent a therapeutic target.

FITC-induced skin inflammation requires CRTH2
=============================================

In this article, **Boehme *et al.* (p. 81)** examine FITC-induced murine contact sensitivity and undertake gene-expression analysis after treatment with a CRTH2 (chemoattractant receptor homologous molecule expressed on T~h~2 cells) antagonist. Decreased transcription of a wide range of inflammatory mediators occurred. This correlated with decreased levels of many cytokines and chemokines. The authors conclude that CRTH inhibits multiple pathways.

Substrate recognition by human chymase
======================================

Chymase is a major component of mast cell granules but its substrate range has still not been fully elucidated. **Hellman and colleagues (p. 95)** use a phage-displayed random nonapeptide library to show that human chymase has a fairly narrow substrate-recognition profile. The results will help predict and identify substrates, and thus suggest novel functions for chymase.
